Journal Article

Semaphorin 3G exacerbates joint inflammation through the accumulation and proliferation of macrophages in the synovium

Ohtori, Seiji, Nakajima, Hiroshi, Tanaka, Shigeru, Etori, Keishi, Ikeda, Kei, Maezawa, Yoshiro, Nakamura, Junichi, Shoda, Jumpei, Hattori, Koto, Betsholtz, Christer, Suto, Akira, Kasuya, Tadamichi, Suzuki, Kotaro, Takemoto, Minoru, Yokote, Koutaro, Maezawa, Yuko

2022

Overview

Objectives Methotrexate (MTX) is an anchor drug for the treatment of rheumatoid arthritis (RA). However, the precise mechanisms by which MTX stalls RA progression and alleviates the ensuing disease effects remain unknown. The aim of the present study was to identify novel therapeutic target molecules, the expression patterns of which are affected by MTX in patients with RA. Methods CD4 + T cells from 28 treatment-naïve patients with RA before and 3 months after the initiation of MTX treatment were subjected to DNA microarray analyses. The expression levels of semaphorin 3G, a differentially expressed gene, and its receptor, neuropilin-2, were evaluated in the RA synovium and collagen-induced arthritis synovium. Collagen-induced arthritis and collagen antibody-induced arthritis were induced in semaphorin3G-deficient mice and control mice, and the clinical score, histological score, and serum cytokines were assessed. The migration and proliferation of semaphorin 3G-stimulated bone marrow-derived macrophages were analyzed in vitro. The effect of local semaphorin 3G administration on the clinical score and number of infiltrating macrophages during collagen antibody-induced arthritis was evaluated. Results Semaphorin 3G expression in CD4 + T cells was downregulated by MTX treatment in RA patients. It was determined that semaphorin 3G is expressed in RA but not in the osteoarthritis synovium; its receptor neuropilin-2 is primarily expressed on activated macrophages. Semaphorin3G deficiency ameliorated collagen-induced arthritis and collagen antibody-induced arthritis. Semaphorin 3G stimulation enhanced the migration and proliferation of bone marrow-derived macrophages. Local administration of semaphorin 3G deteriorated collagen antibody-induced arthritis and increased the number of infiltrating macrophages. Conclusions Upregulation of semaphorin 3G in the RA synovium is a novel mechanism that exacerbates joint inflammation, leading to further deterioration, through macrophage accumulation.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Animals / Arthritis / Arthritis, Experimental - pathology / Arthritis, Rheumatoid - drug therapy / Bone marrow / Cell Proliferation / Collagen / Collagen - metabolism / Complications and side effects / Development and progression / Disease / Drug therapy / Gene expression / Genomes / Health aspects / Humans / Inflammation / Inflammation - pathology / Lymphocytes / Macrophage / Macrophages / Macrophages - metabolism / Medicine / Medicine & Public Health / Methotrexate / Methotrexate - pharmacology / Methotrexate - therapeutic use / Mice / Neuropilin-2 / Neuropilin-2 - metabolism / Orthopedics / Polyclonal antibodies / Rheumatoid arthritis / Rheumatology / Semaphorin / Semaphorins / Semaphorins - metabolism / Synovial Membrane - metabolism / Synovial membranes / Variance analysis